Final published version
Licence: CC BY: Creative Commons Attribution 4.0 International License
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - A dominant role for the methyl-CpG-binding protein Mbd2 in controlling Th2 induction by dendritic cells
AU - Cook, Peter C
AU - Owen, Heather
AU - Deaton, Aimée M
AU - Borger, Jessica G
AU - Brown, Sheila L
AU - Clouaire, Thomas
AU - Jones, Gareth-Rhys
AU - Jones, Lucy H
AU - Lundie, Rachel J
AU - Marley, Angela K
AU - Morrison, Vicky L
AU - Phythian-Adams, Alexander T
AU - Wachter, Elisabeth
AU - Webb, Lauren M
AU - Sutherland, Tara E
AU - Thomas, Graham D
AU - Grainger, John R
AU - Selfridge, Jim
AU - McKenzie, Andrew N J
AU - Allen, Judith E
AU - Fagerholm, Susanna C
AU - Maizels, Rick M
AU - Ivens, Alasdair C
AU - Bird, Adrian
AU - MacDonald, Andrew S
PY - 2015/4/24
Y1 - 2015/4/24
N2 - Dendritic cells (DCs) direct CD4(+) T-cell differentiation into diverse helper (Th) subsets that are required for protection against varied infections. However, the mechanisms used by DCs to promote Th2 responses, which are important both for immunity to helminth infection and in allergic disease, are currently poorly understood. We demonstrate a key role for the protein methyl-CpG-binding domain-2 (Mbd2), which links DNA methylation to repressive chromatin structure, in regulating expression of a range of genes that are associated with optimal DC activation and function. In the absence of Mbd2, DCs display reduced phenotypic activation and a markedly impaired capacity to initiate Th2 immunity against helminths or allergens. These data identify an epigenetic mechanism that is central to the activation of CD4(+) T-cell responses by DCs, particularly in Th2 settings, and reveal methyl-CpG-binding proteins and the genes under their control as possible therapeutic targets for type-2 inflammation.
AB - Dendritic cells (DCs) direct CD4(+) T-cell differentiation into diverse helper (Th) subsets that are required for protection against varied infections. However, the mechanisms used by DCs to promote Th2 responses, which are important both for immunity to helminth infection and in allergic disease, are currently poorly understood. We demonstrate a key role for the protein methyl-CpG-binding domain-2 (Mbd2), which links DNA methylation to repressive chromatin structure, in regulating expression of a range of genes that are associated with optimal DC activation and function. In the absence of Mbd2, DCs display reduced phenotypic activation and a markedly impaired capacity to initiate Th2 immunity against helminths or allergens. These data identify an epigenetic mechanism that is central to the activation of CD4(+) T-cell responses by DCs, particularly in Th2 settings, and reveal methyl-CpG-binding proteins and the genes under their control as possible therapeutic targets for type-2 inflammation.
KW - Allergens
KW - Animals
KW - CD4-Positive T-Lymphocytes
KW - Cell Polarity
KW - Chromatin Immunoprecipitation
KW - DNA Methylation
KW - DNA-Binding Proteins
KW - Dendritic Cells
KW - Enzyme-Linked Immunosorbent Assay
KW - Epigenesis, Genetic
KW - Flow Cytometry
KW - Gene Expression Regulation
KW - Hypersensitivity
KW - Lymphocyte Activation
KW - Mice
KW - Mice, Knockout
KW - Pyroglyphidae
KW - RNA, Messenger
KW - Reverse Transcriptase Polymerase Chain Reaction
KW - Schistosoma mansoni
KW - Schistosomiasis mansoni
KW - Th2 Cells
KW - Journal Article
KW - Research Support, N.I.H., Extramural
KW - Research Support, Non-U.S. Gov't
U2 - 10.1038/ncomms7920
DO - 10.1038/ncomms7920
M3 - Journal article
C2 - 25908537
VL - 6
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
M1 - 6920
ER -